The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control - Wikidata - thesis-toulmin - TriplyDB

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

http://www.wikidata.org/entity/Q24629879

about

The Use of Rat and Mouse Models in Bariatric Surgery Experiments Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?Recent advances in metabolic and bariatric surgery Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review Pharmacology and physiology of gastrointestinal enteroendocrine cells Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms Bile acid metabolism and signaling Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?Bile acids, obesity, and the metabolic syndrome Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome Bile acid signaling in metabolic disease and drug therapy Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.Farnesoid X Receptor an Emerging Target to Combat Obesity.Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery Does gastric bypass surgery change body weight set point?Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity.Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes.The physiology underlying Roux-en-Y gastric bypass: a status report.Gut chemosensing mechanisms.Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats Gastrointestinal changes after bariatric surgery.Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission.Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes.Gastrointestinal hormones and bariatric surgery-induced weight loss Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.Malabsorption as a Therapeutic Approach in Bariatric Surgery.A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism?Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation.Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery

P2860

Q26740015-FE576FDE-6CFE-4BB3-80F5-F383BF891532 Q26741066-ADE8F9ED-B955-4B75-9B5C-853F383BBA7F Q26741527-5B888015-EBFF-4259-BDE7-B3D319F72E46 Q26745203-0C51C26A-A52F-467B-8D18-A4547B46F45D Q26780440-B96AB2BF-C008-4736-92CB-4449B52F541D Q26799380-98850E0E-5A2F-4318-92B8-23B4DD6D1739 Q27000617-CB2CE514-7C6B-4E0B-A8E1-4109CAEB5765 Q27002873-2EFFF663-A8EF-4E70-8FB3-223C302FB1CD Q27010589-E26E9A2B-C905-490E-A858-597C0E4F5376 Q27015789-BD82A423-E692-4907-B427-9528DD41024D Q27020976-2DC5F894-00D9-4798-905D-5220BD40BE40 Q28070321-EAA05034-1FFF-4FF5-B060-2F3245A95931 Q28244875-D5CEBE03-1A50-4880-A825-82AFCC9A40D6 Q28659292-936F0256-8F9D-4972-AEA2-1872B9F28752 Q30235507-0AEA7266-2882-4EE4-8851-B1D1049E80D3 Q30277979-55D9E12C-502B-487C-BEB7-9C04BA865616 Q33761529-B037373F-AD4C-468C-8A27-1D1D7B2D9F2F Q33838159-CE147D41-EF42-4008-B010-EA09A81E9147 Q34146701-BEAB24C4-774F-4E67-9606-526DF046B8A8 Q34366918-88151EDC-06FE-44DC-880C-67A257BF2414 Q34406806-FAC617A4-05F3-4F3A-81C9-E657F3092A83 Q34425909-52C806C3-2C25-4670-A543-3D56C3EB9829 Q34503739-F8221484-7D0A-482C-87C0-B5AF571646DA Q34542785-66B8B631-4D5D-4B0C-BAF4-9B98C888AF2F Q35043446-A58382E7-7D9A-446A-AD85-5E89850252F1 Q35183915-12E31ADC-161A-477C-8A2A-49544ABB5BB1 Q35208562-F0871594-9498-4480-8372-2E858B730EA9 Q35340286-FA7D8B40-5ADD-452B-8A25-8E42CA75D815 Q35564937-46374A55-6249-4D0C-BB4E-190B8EF76423 Q35577851-2E8877FD-6A86-4610-8BFE-B9D4981A4821 Q35581251-9480B75B-C536-4557-986E-6C4F30B52363 Q35703158-3DEA2FBA-2578-4970-A9A5-C3E79853E307 Q35836340-BB10036E-AA12-44DC-A38A-CCE86521C30D Q35885840-410E9364-5C09-49AB-9B2D-605D5D200167 Q35904835-19C83AD4-B132-42EB-A54C-A6E4503F96FA Q35956912-4C9537D8-F42A-47B1-840C-9C62C45A46A7 Q36060415-49FD188A-3659-4A35-8EB1-C43ED987B912 Q36060744-FA588498-0D97-422F-9801-8C5A6113A78C Q36104655-9D731AC6-C87F-4CD1-9BF6-4EFC8D7F53B6 Q36281648-0532DFD5-66AF-4C13-8CDC-533C8B411975

P2860

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

http://www.wikidata.org/entity/Q24629879

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The role of bile after Roux-en ...... nd improving glycaemic control

@ast

The role of bile after Roux-en ...... nd improving glycaemic control

@en

The role of bile after Roux-en ...... nd improving glycaemic control

@nl

type

label

The role of bile after Roux-en ...... nd improving glycaemic control

@ast

The role of bile after Roux-en ...... nd improving glycaemic control

@en

The role of bile after Roux-en ...... nd improving glycaemic control

@nl

prefLabel

The role of bile after Roux-en ...... nd improving glycaemic control

@ast

The role of bile after Roux-en ...... nd improving glycaemic control

@en

The role of bile after Roux-en ...... nd improving glycaemic control

@nl

P1433

Q24629879-3E39BBFF-2DC4-4606-8AE5-D19EF9582A3A

P1476

Q24629879-0B068F0F-332C-4DBC-81BA-CD104474B6A1

P2093

Q24629879-23A99BDB-FE1F-4BC1-B771-B97B477CDCAE

Q24629879-24BB1ABC-4941-4536-ACA7-D9EF53B818CD

Q24629879-29EFC50B-AA57-42E3-A3C8-9A554A35B43A

Q24629879-2AA8D776-BC1E-46C0-B4BF-0C5328ED1BDB

Q24629879-30252ACC-0573-49E8-BF72-921ED93FF462

Q24629879-3C75E095-D6C8-44D3-ABE2-BCFF0AF5335C

Q24629879-5BEB1B75-069A-48DD-AC78-6C501EC604BB

Q24629879-7EA49805-70B4-4C6A-94D1-AB83DAB11CA7

Q24629879-838F7977-5EA1-41E5-97D9-7BA781A4F052

Q24629879-D55F087F-9CE3-42DE-8403-6A59CF8B883E

P2860

Q24629879-08547447-A177-43F5-BB6C-61E16395392D

Q24629879-08CD19C0-CEC5-4D01-A208-0EC4C8E20E9D

Q24629879-08E5743E-D9EF-4256-A184-36200209CC40

Q24629879-0F846518-733E-4485-96FC-F4EB7A9EFEAD

Q24629879-155A7794-3F66-495E-8248-D8142AF3655B

Q24629879-18356DE4-7E9B-4F5A-8B06-E9CF3BFFE916

Q24629879-1BF02E71-934A-49B1-B314-E3566ACF0AE0

Q24629879-24FD2DE4-8BCE-4E9D-97DE-83D41F50DD19

Q24629879-30FC0CEB-2EB0-46D9-87A0-303F536A995B

Q24629879-34B473BE-065C-489F-BE33-5FB85BE5471D

P304

Q24629879-7414DDBD-3BE5-417B-AE47-2F2CC5D68694

P31

Q24629879-FFDC8C0A-0960-49A7-AA41-0484B358BFBB

P3181

Q24629879-522C6549-8BDD-42C2-B282-5DC3B9C1DCD4

P356

Q24629879-63AE0F03-BEFB-4BE5-8642-6267A84FDDE3

P407

Q24629879-0434C9F1-F909-4E7A-9124-1B38020ACD11

P433

Q24629879-BCF0656A-B644-415C-B8C8-BDE7F1577056

P478

Q24629879-9DECF1D7-7F5D-4C8F-89CA-FB3D9384B924

P577

Q24629879-4DA77BF4-21D1-4C7E-9FAE-D47D45DE3E6D

P5875

Q24629879-0A5868F1-A52F-4322-89E1-F034F4ABA593

P698

Q24629879-CD4CA788-19BD-4829-AB7C-34C5C8426BEA

P932

Q24629879-FA138674-C06B-440A-BA40-6955DFE13BD9

P3181

P356

P1433

P1476

The role of bile after Roux-en ...... nd improving glycaemic control

@en

P2093

Carel W le Roux

http://www.w3.org/2001/XMLSchema#string

Clare Glicksman

http://www.w3.org/2001/XMLSchema#string

David Mahon

http://www.w3.org/2001/XMLSchema#string

Dimitri J Pournaras

http://www.w3.org/2001/XMLSchema#string

Jamie Alaghband-Zadeh

http://www.w3.org/2001/XMLSchema#string

Jan H R Bekker

http://www.w3.org/2001/XMLSchema#string

Julian R F Walters

http://www.w3.org/2001/XMLSchema#string

Mohammad A Ghatei

http://www.w3.org/2001/XMLSchema#string

Richard Welbourn

http://www.w3.org/2001/XMLSchema#string

Royce P Vincent

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

Inhibition of food intake in obese subjects by peptide YY3-36

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

Farnesoid X receptor is essential for normal glucose homeostasis

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.

P304

3613-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1394566

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/EN.2011-2145

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225278410

http://www.w3.org/2001/XMLSchema#string

P698

22673227

http://www.w3.org/2001/XMLSchema#string

P932

3404349

http://www.w3.org/2001/XMLSchema#string